Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H24ClFO7 |
Molecular Weight | 454.873 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)C=C1F
InChI
InChIKey=HYTPDMFFHVZBOR-VNXMGFANSA-N
InChI=1S/C22H24ClFO7/c1-2-29-17-6-3-12(8-16(17)24)7-13-9-14(4-5-15(13)23)22-20(28)18(26)19(27)21(10-25,31-22)11-30-22/h3-6,8-9,18-20,25-28H,2,7,10-11H2,1H3/t18-,19-,20+,21+,22+/m0/s1
Molecular Formula | C22H24ClFO7 |
Molecular Weight | 454.873 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Henagliflozin (also known as SHR3824) was developed by Jiangsu HengRui Medicine as a sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus. This drug successfully passed phase I clinical trials, however, information about further development is not available.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
SHR3824, a novel selective inhibitor of renal sodium glucose cotransporter 2, exhibits antidiabetic efficacy in rodent models. | 2014 May |
|
Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus. | 2016 Mar |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02346175
to evaluate the pharmacodynamics (PD), pharmacokinetics (PK), safety and tolerability following single and multiple oral doses of 5mg to 20 mg SHR3824 in Type 2 diabetes mellitus patients.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:57:18 GMT 2023
by
admin
on
Fri Dec 15 16:57:18 GMT 2023
|
Record UNII |
21P2M98388
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
21P2M98388
Created by
admin on Fri Dec 15 16:57:18 GMT 2023 , Edited by admin on Fri Dec 15 16:57:18 GMT 2023
|
PRIMARY | |||
|
56832738
Created by
admin on Fri Dec 15 16:57:18 GMT 2023 , Edited by admin on Fri Dec 15 16:57:18 GMT 2023
|
PRIMARY | |||
|
DB11939
Created by
admin on Fri Dec 15 16:57:18 GMT 2023 , Edited by admin on Fri Dec 15 16:57:18 GMT 2023
|
PRIMARY | |||
|
1623804-44-3
Created by
admin on Fri Dec 15 16:57:18 GMT 2023 , Edited by admin on Fri Dec 15 16:57:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |